Regeneron Pharmaceuticals
REGN
#231
Rank
$77.12 B
Marketcap
$701.85
Share price
-0.90%
Change (1 day)
-16.63%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2024 (TTM): $4.96 Billion USD

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are $13.84 Billion USD. In 2023 the company made an earning of $4.19 Billion USD a decrease over its 2022 earnings that were of $4.85 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $4.96 B18.34%
2023 $4.19 B-13.57%
2022 $4.85 B-47.9%
2021 $9.32 B144.75%
2020 $3.81 B56.86%
2019 $2.42 B-4.87%
2018 $2.55 B22.86%
2017 $2.07 B56.3%
2016 $1.32 B8.55%
2015 $1.22 B54.53%
2014 $0.79 B11.14%
2013 $0.71 B72.13%
2012 $0.41 B-285.93%
2011 -$0.23 Billion121.73%
2010 -$0.11 Billion37.18%
2009 -$73.28 Million-14.6%
2008 -$85.82 Million-25.02%
2007 -$0.12 Billion6.32%
2006 -$0.11 Billion-186.52%
2005 $0.12 B2103.7%
2004 $5.64 M-105.66%
2003 -$99.78 Million-18.18%
2002 -$0.13 Billion42.33%
2001 -$85.69 Million129.35%
2000 -$37.36 Million51.87%
1999 -$24.6 Million92.19%
1998 -$12.8 Million66.23%
1997 -$7.7 Million-55.49%
1996 -$17.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$4.67 B-5.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.19 Billion-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.90 B-61.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.39 B 270.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.73 B 156.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$7.40 B 49.07%๐Ÿ‡ซ๐Ÿ‡ท France